Your browser doesn't support javascript.
loading
Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic study.
Kado, Joseph; Salman, Sam; Hla, Thel K; Enkel, Stephanie; Henderson, Robert; Hand, Robert M; Hort, Adam; Page-Sharp, Madhu; Batty, Kevin; Moore, Brioni R; Bennett, Julie; Anderson, Anneka; Carapetis, Jonathan; Manning, Laurens.
Afiliação
  • Kado J; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
  • Salman S; Medical School, University of Western Australia, Perth, Western Australia, Australia.
  • Hla TK; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
  • Enkel S; Medical School, University of Western Australia, Perth, Western Australia, Australia.
  • Henderson R; Clinical Pharmacology and Toxicology Unit, PathWest, Western Australia, Australia.
  • Hand RM; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
  • Hort A; Medical School, University of Western Australia, Perth, Western Australia, Australia.
  • Page-Sharp M; Department of Infectious Diseases, Fiona Stanley Hospital, Perth, Western Australia, Australia.
  • Batty K; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
  • Moore BR; Medical School, University of Western Australia, Perth, Western Australia, Australia.
  • Bennett J; Medical Imaging Department, Perth Children's Hospital, Nedlands, Western Australia, Australia.
  • Anderson A; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
  • Carapetis J; Department of Infectious Diseases, Royal Perth Hospital, Perth, Western Australia, Australia.
  • Manning L; Western Australian Country Health Service, Perth, Western Australia, Australia.
Antimicrob Agents Chemother ; 67(12): e0096223, 2023 12 14.
Article em En | MEDLINE | ID: mdl-37971244

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Reumática / Cardiopatia Reumática Limite: Adult / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Reumática / Cardiopatia Reumática Limite: Adult / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália